Skip to main content

Parag Mallick

Analyst

Chief Scientist

Equibles does not estimate personal net worth.

About Parag Mallick

Parag Mallick is recorded as Analyst at Chief Scientist. Parag Mallick has spoken on 14 earnings calls across 1 company, most recently for Nautilus Biotechnology, Inc. on October 27, 2026. The companies whose calls Parag Mallick spoke on are classified in the Healthcare sector.

Parag Mallick on recent calls

“And I think we've been excited by the diversity of use cases that we're seeing. In general, I would categorize them into sort of three buckets. One is fundamental mechanistic biology.”
Analyst — Chief Scientist, Nautilus Q3 2026 Earnings Conference Call ·
“I want to start with what we're hearing from customers, because it is directly shaping how we work. The heart of it is one word, resolution.”
Analyst — Chief Scientist, Nautilus Q2 2026 Earnings Conference Call ·
“Overall, Q1 was a productive quarter for our product and scientific teams. From the Voyager platform development perspective, we made meaningful progress across our assay portfolio.”
Analyst — Chief Scientist, Nautilus Biotechnology, Inc. Q1 FY2026 Earnings Call ·
“I'll now provide an update on our technology and product progress, including what we're learning from our development work and the external validation we're seeing through collaborations.”
Analyst — Chief Scientist, Nautilus Biotechnology, Inc. Q4 FY2025 Earnings Call ·
“Q2 marked a major inflection point in our scientific journey. As Sujil mentioned, this quarter we shared a preprint of a manuscript illustrating how our iterative mapping method enables a unique capability on the Nautilus platform.”
Nautilus Biotechnology, Inc. Q2 FY2025 Earnings Call ·

Affiliation history

  • Chief Scientist

    Analyst

    Source not stated

    Current

Company network

Recent activity

Show 2 earlier activities